Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Daiichi Sankyo

Generated: August 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075737

« Back to Dashboard

NDA 075737 describes MINOXIDIL EXTRA STRENGTH (FOR MEN), which is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Avacor Prods, Perrigo, Perrigo New York, and Wockhardt Bio Ag, and is included in six NDAs. It is available from twenty-three suppliers. Additional details are available on the MINOXIDIL EXTRA STRENGTH (FOR MEN) profile page.

The generic ingredient in MINOXIDIL EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 075737
Applicant:Perrigo New York
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 075737

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength5%
Approval Date:Mar 15, 2002TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Fish and Richardson
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.